Health News (Reuters)

Loxo Oncology's targeted RET drug shows promise in early trial

CHICAGO (Reuters) - An experimental Loxo Oncology Inc drug that targets cancers with mistakes in the RET gene led to tumor shrinkage in nearly 70 percent of patients regardless of where their cancer originated, according to preliminary data from a small study released on Wednesday.

Merck KGaA's lung cancer drugs show promise in early-stage trials

FRANKFURT (Reuters) - Germany's Merck KGaA said two of its experimental oncology drugs showed early signs of promise in certain lung cancer patients, potentially helping the company's efforts to find drug-industry partners to share further development costs.

FDA reports inaccuracy in IQVIA opioid sales data

(Reuters) - The U.S. Food & Drug Administration said on Wednesday it found inaccuracies in sales data of opioid drug products provided by IQVIA Holdings Inc, a vendor it contracts.

Evolus investors frown as FDA declines to approve Botox rival

(Reuters) - U.S. health regulators on Wednesday declined to approve Evolus Inc's rival product to Allergan Plc's Botox, citing deficiencies related to the chemistry and manufacturing of its potential treatment for frown lines, sending its shares down as much as 35 percent.

Congo receives first doses of Ebola vaccine amid outbreak

KINSHASA (Reuters) - The first batch of 4,000 experimental Ebola vaccines to combat an outbreak suspected to have killed 20 people arrived in Congo's capital Kinshasa on Wednesday, said a Reuters witness at the airport.

Sivantos owner EQT forges $8 billion hearing aid deal

COPENHAGEN/FRANKFURT (Reuters) - Hearing aid makers Widex and Sivantos agreed to merge on Wednesday to form the world's third-largest supplier behind market leaders Sonova and William Demant.

Competition heats up for controversial a2 Milk Company

SYDNEY/WELLINGTON (Reuters) - Stay-at-home mother Anna Wei wanted the best milk formula to feed her firstborn, so she chose the most expensive brand her money could buy: Platinum by a2 Milk Company Ltd.

Groups sue to stop Iowa's 'fetal heartbeat' abortion ban

(Reuters) - Planned Parenthood and the American Civil Liberties Union's Iowa branch said they sued on Tuesday to stop a state law that would impose the strictest abortion limits in the United States from taking effect.

U.S. state lawsuits against Purdue Pharma over opioid epidemic mount

NEW YORK (Reuters) - Litigation against OxyContin maker Purdue Pharma LP is intensifying as six more U.S. states on Tuesday announced lawsuits, accusing the company of fueling a national opioid epidemic by deceptively marketing its prescription painkillers to generate billions of dollars in sales.

Obesity tied to risk of irregular heart rhythm in both genders

(Reuters Health) - Both men and women who are overweight or obese may be more likely to develop an irregular heart rhythm condition known as atrial fibrillation than their counterparts who maintain a healthy weight, a recent study suggests.

Pfizer's biosimilar of anemia treatments gets FDA nod

(Reuters) - Pfizer Inc's biosimilar of anemia treatments from Amgen Inc and Johnson & Johnson was approved by U.S. health regulators on Tuesday setting it up to compete against the established brands.

Nestle to cut more sugar and salt in its products

VEVEY, Switzerland (Reuters) - Nestle will make further cuts to the amount of sugar, salt and saturated fats in its products as it tries to improve the image of packaged foods in the eyes of health-conscious consumers, the Swiss group said on Tuesday. Nestle and its rivals are under pressure from a shift in consumer preferences toward healthier food and away from processed products such as instant noodles and frozen pizza.

Pages